Are mitotic index and lymphocyte proliferation kinetics reproducible endpoints in genetic toxicology testing?
Lymphocyte proliferation kinetics is an endpoint used in genetic toxicology which has recently been proposed as an alternative for the screening of new cytostatic drugs. Although great variability for this parameter has been reported, there are few reports about the intra- and inter-individual variation of the effects of chemicals on this endpoint. For this reason, experiments were conducted to evaluate the reproducibility of the effects of a well-known cytostatic, mitomycin C (MMC), on the proliferation of PHA-stimulated human lymphocytes, both over time and among samples from several donors. Although inter-individual variability was shown in both parameters in untreated and treated cultures, this variation was not significant. Intra-individual variation was significantly detected only in cultures treated with 0.1 microM MMC.
Rojas
E
E
Instituto de Investigaciones Biomédicas, UNAM, Mexico D.F.
Montero
R
R
Herrera
L A
LA
Sordo
M
M
Gonsebatt
M E
ME
Rodriguez
R
R
Ostrosky-Wegman
P
P
D000328:Adult; D005260:Female; D006801:Humans; D007700:Kinetics; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D016685:Mitomycin / Q000633:toxicity*; D008940:Mitotic Index; D009152:Mutagenicity Tests / Q000379:methods*; D015203:Reproducibility of Results
D016685:Mitomycin